HER2-Enriched Subtype and ERBB2 Expression in HER2-Positive Breast Cancer Treated with Dual HER2 Blockade

Aleix Prat, Tomás Pascual, Carmine De Angelis, Carolina Gutierrez, Antonio Llombart-Cussac, Tao Wang, Javier Cortés, Brent Rexer, Laia Paré, Andres Forero, Antonio C. Wolff, Serafín Morales, Barbara Adamo, Fara Brasó-Maristany, Maria Vidal, Jamunarani Veeraraghavan, Ian Krop, Patricia Galván, Anne C. Pavlick, Begoña BermejoMiguel Izquierdo, Vanessa Rodrik-Outmezguine, Jorge S. Reis-Filho, Susan G. Hilsenbeck, Mafalda Oliveira, Maria Vittoria DIeci, Gaia Griguolo, Roberta Fasani, Paolo Nuciforo, Joel S. Parker, Pierfranco Conte, Rachel Schiff, Valentina Guarneri, C. Kent Osborne, Mothaffar F. Rimawi

Research output: Contribution to journal › Article › peer-review

31 Scopus citations

Fingerprint

Dive into the research topics of 'HER2-Enriched Subtype and ERBB2 Expression in HER2-Positive Breast Cancer Treated with Dual HER2 Blockade'. Together they form a unique fingerprint.

Medicine & Life Sciences